Member Info for scardey_cat

Yep, it's 15% sensitivity and 12% specificity. Does that help?

The great thing is you can call Ndn a patronising twat knowing he'll see your post, but can't come back on it because he'll look foolish having said he's filtered you. Let's see if it works.

Ndn, you're a patronising, boring, stupid twat.

@marik. You'll be mightily relieved to know that he only pretends to filter people. His favourite line is 'I caught the last post, even though I filtered him', which is his rather silly attempt to explain how he manages to 'see' filtered posts.

“Medusa has always been a 'sales and marketing' organisation, anyone who's been in Avacta from pre-covid knows that.”

@seethreeIPO
From my basic understanding of the English language, that sentence implies Medusa existed in the Avacta pre-covid days.
To borrow your phrase, I think it's rather clear.

Anyway, I knew what you meant, just didn’t like your patronising tone and was biting back.
No big deal.

Lucky guy, who's doing the sucking?

@marik
That's why MHRA have described DHSC's use of the test as a 'stretch' in terms of the given EUA.

Today too early for FOMO @mortgage, thursday/friday is the time for that.

@seethree
Your first sentence implies Medusa existed pre Avacta covid.
You do know that Medusa was only formed in the last 12 months don't you?

Cheers Robbo, good effort.

Don't be greedy PL, gently, gently catchy monkey :-)

If it's affirmative, just post a one liner on here "Boohoo thumbs up" :-)

Robbo, why don't you ask your mate the obvious, will Medusa be manufacturing AffiDx. Medusa aren't listed, so that's not insider trading. If your mate can't answer that, then maybe he doesn't know Richard Hughes (or Kamani) that well.

Increase, out of interest, which vaccine have you had? Have you reported your side effects?

Sounds familiar.
https://www.cityam.com/breakthrough-uk-researchers-find-new-covid-19-treatment-that-uses-artificial-antibodies/

[In March, the DH published further analysis of data collected during phase 4 of the Porton Down and Oxford University study, which evaluated the performance of the Innova tests against polymerase-chain-reaction (PCR) tests.
The analysis showed that the Innova tests have “a specificity of at least 99.9% when used to test in the community”, which means “fewer than one false positive in every 1,000 lateral flow tests carried out”.]

It's getting beyond a joke this. The only mention of any % measure in this whole article is 99.9% specificity. Absolutely no mention of the rubbish sensitivity. In the link they provide, buried away in the details is the 'real world' sensitivity measure.
[ Total LFT+ 339 PCR+ 677 Sensitivity 50.1% ]
It's almost like a conspiracy of silence. Absolutely maddening.

"I suspect that the Innova test hasn’t been anywhere near Porton, it was apparently given Emergency Use Authorisation before it had even been tested."

Talking through his rear end, then. Innova passed PD 11 Sep 2020 - EUA given Dec 2020.

https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/outcome-of-the-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices

Yep, from the FT article:
"is set to expire on June 22, unless it is renewed by the MHRA"

MCB55
Presentation = 21st June
Innova EUA expiry = 22nd June
Pretty sure about that, but will check the expiry date out.

It's the 22nd June wyn.

Just wondering if this comment in the Telegraph was from Medusa's Richard Hughes.

Reply
Richard Hughes
15 Jun 2021 1:08AM
Well, it would be very embarrassing if we had a lateral flow test that actually worked reliably. It would show up the previous dreadful procurement decisions.

Unusually probably wrong to blame the politicians, this stinks of civil service incompetence and cover up